nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—SLC22A3—Melphalan—ovarian cancer	0.578	0.844	CbGbCtD
Phenoxybenzamine—CYP3A4—Topotecan—ovarian cancer	0.0378	0.0552	CbGbCtD
Phenoxybenzamine—CYP3A4—Vinorelbine—ovarian cancer	0.0266	0.0389	CbGbCtD
Phenoxybenzamine—CYP3A4—Paclitaxel—ovarian cancer	0.0187	0.0273	CbGbCtD
Phenoxybenzamine—CYP3A4—Docetaxel—ovarian cancer	0.0135	0.0198	CbGbCtD
Phenoxybenzamine—CYP3A4—Doxorubicin—ovarian cancer	0.0101	0.0147	CbGbCtD
Phenoxybenzamine—CALM2—oviduct—ovarian cancer	0.00654	0.0608	CbGeAlD
Phenoxybenzamine—ADRA1D—epithelium—ovarian cancer	0.00268	0.0249	CbGeAlD
Phenoxybenzamine—CALM3—myometrium—ovarian cancer	0.00266	0.0248	CbGeAlD
Phenoxybenzamine—SLC22A3—myometrium—ovarian cancer	0.00246	0.0229	CbGeAlD
Phenoxybenzamine—SLC22A3—embryo—ovarian cancer	0.00237	0.022	CbGeAlD
Phenoxybenzamine—CALM2—myometrium—ovarian cancer	0.00209	0.0195	CbGeAlD
Phenoxybenzamine—CALM1—myometrium—ovarian cancer	0.00208	0.0194	CbGeAlD
Phenoxybenzamine—CALM3—uterine cervix—ovarian cancer	0.00207	0.0193	CbGeAlD
Phenoxybenzamine—CALM2—embryo—ovarian cancer	0.00201	0.0187	CbGeAlD
Phenoxybenzamine—CALM1—embryo—ovarian cancer	0.002	0.0186	CbGeAlD
Phenoxybenzamine—ADRA1D—female reproductive system—ovarian cancer	0.00199	0.0185	CbGeAlD
Phenoxybenzamine—CALM3—decidua—ovarian cancer	0.00198	0.0184	CbGeAlD
Phenoxybenzamine—SLC22A3—uterine cervix—ovarian cancer	0.00192	0.0178	CbGeAlD
Phenoxybenzamine—CALM3—endometrium—ovarian cancer	0.00188	0.0174	CbGeAlD
Phenoxybenzamine—ADRA2C—myometrium—ovarian cancer	0.00187	0.0174	CbGeAlD
Phenoxybenzamine—SLC22A3—endometrium—ovarian cancer	0.00173	0.0161	CbGeAlD
Phenoxybenzamine—CALM3—uterus—ovarian cancer	0.00173	0.0161	CbGeAlD
Phenoxybenzamine—CALM2—epithelium—ovarian cancer	0.00164	0.0153	CbGeAlD
Phenoxybenzamine—CALM1—epithelium—ovarian cancer	0.00163	0.0152	CbGeAlD
Phenoxybenzamine—CALM2—uterine cervix—ovarian cancer	0.00163	0.0151	CbGeAlD
Phenoxybenzamine—CALM1—uterine cervix—ovarian cancer	0.00162	0.0151	CbGeAlD
Phenoxybenzamine—SLC22A3—gonad—ovarian cancer	0.00161	0.015	CbGeAlD
Phenoxybenzamine—CALM2—decidua—ovarian cancer	0.00155	0.0144	CbGeAlD
Phenoxybenzamine—CALM1—decidua—ovarian cancer	0.00154	0.0144	CbGeAlD
Phenoxybenzamine—ADRA1A—epithelium—ovarian cancer	0.00154	0.0143	CbGeAlD
Phenoxybenzamine—ADRA2A—myometrium—ovarian cancer	0.00149	0.0139	CbGeAlD
Phenoxybenzamine—CALM2—endometrium—ovarian cancer	0.00147	0.0137	CbGeAlD
Phenoxybenzamine—CALM3—bone marrow—ovarian cancer	0.00147	0.0136	CbGeAlD
Phenoxybenzamine—CALM1—endometrium—ovarian cancer	0.00147	0.0136	CbGeAlD
Phenoxybenzamine—ADRA2C—uterine cervix—ovarian cancer	0.00146	0.0135	CbGeAlD
Phenoxybenzamine—SLC22A3—female reproductive system—ovarian cancer	0.00144	0.0134	CbGeAlD
Phenoxybenzamine—CALM3—female gonad—ovarian cancer	0.00141	0.0131	CbGeAlD
Phenoxybenzamine—CALM3—vagina—ovarian cancer	0.0014	0.0131	CbGeAlD
Phenoxybenzamine—ADRA2C—decidua—ovarian cancer	0.00139	0.0129	CbGeAlD
Phenoxybenzamine—CALM2—gonad—ovarian cancer	0.00137	0.0127	CbGeAlD
Phenoxybenzamine—CALM1—gonad—ovarian cancer	0.00136	0.0126	CbGeAlD
Phenoxybenzamine—SLC22A1—vagina—ovarian cancer	0.00136	0.0126	CbGeAlD
Phenoxybenzamine—CALM2—uterus—ovarian cancer	0.00136	0.0126	CbGeAlD
Phenoxybenzamine—CALM1—uterus—ovarian cancer	0.00135	0.0126	CbGeAlD
Phenoxybenzamine—ADRA2C—endometrium—ovarian cancer	0.00132	0.0122	CbGeAlD
Phenoxybenzamine—SLC22A3—female gonad—ovarian cancer	0.00131	0.0122	CbGeAlD
Phenoxybenzamine—SLC22A3—vagina—ovarian cancer	0.0013	0.0121	CbGeAlD
Phenoxybenzamine—CALM3—testis—ovarian cancer	0.00125	0.0117	CbGeAlD
Phenoxybenzamine—CALM2—female reproductive system—ovarian cancer	0.00122	0.0113	CbGeAlD
Phenoxybenzamine—CALM1—female reproductive system—ovarian cancer	0.00121	0.0113	CbGeAlD
Phenoxybenzamine—ADRA2C—uterus—ovarian cancer	0.00121	0.0113	CbGeAlD
Phenoxybenzamine—ADRA2A—uterine cervix—ovarian cancer	0.00116	0.0108	CbGeAlD
Phenoxybenzamine—SLC22A3—testis—ovarian cancer	0.00116	0.0108	CbGeAlD
Phenoxybenzamine—CALM2—bone marrow—ovarian cancer	0.00115	0.0107	CbGeAlD
Phenoxybenzamine—CALM1—bone marrow—ovarian cancer	0.00115	0.0107	CbGeAlD
Phenoxybenzamine—Ospemifene—ESR1—ovarian cancer	0.00111	0.204	CrCbGaD
Phenoxybenzamine—CALM2—female gonad—ovarian cancer	0.00111	0.0103	CbGeAlD
Phenoxybenzamine—ADRA2A—decidua—ovarian cancer	0.00111	0.0103	CbGeAlD
Phenoxybenzamine—CALM1—female gonad—ovarian cancer	0.0011	0.0103	CbGeAlD
Phenoxybenzamine—CALM2—vagina—ovarian cancer	0.0011	0.0103	CbGeAlD
Phenoxybenzamine—CALM1—vagina—ovarian cancer	0.0011	0.0102	CbGeAlD
Phenoxybenzamine—ADRA2A—endometrium—ovarian cancer	0.00105	0.00976	CbGeAlD
Phenoxybenzamine—ADRA2C—female gonad—ovarian cancer	0.000992	0.00922	CbGeAlD
Phenoxybenzamine—ADRA2C—vagina—ovarian cancer	0.000986	0.00917	CbGeAlD
Phenoxybenzamine—CALM2—testis—ovarian cancer	0.000984	0.00915	CbGeAlD
Phenoxybenzamine—CALM1—testis—ovarian cancer	0.00098	0.00911	CbGeAlD
Phenoxybenzamine—ADRA2A—gonad—ovarian cancer	0.000974	0.00906	CbGeAlD
Phenoxybenzamine—ADRA2A—uterus—ovarian cancer	0.000968	0.009	CbGeAlD
Phenoxybenzamine—CALM3—lymph node—ovarian cancer	0.000909	0.00845	CbGeAlD
Phenoxybenzamine—Toremifene—ESR1—ovarian cancer	0.000907	0.166	CrCbGaD
Phenoxybenzamine—ADRA2C—testis—ovarian cancer	0.00088	0.00818	CbGeAlD
Phenoxybenzamine—ADRA2A—female reproductive system—ovarian cancer	0.00087	0.00809	CbGeAlD
Phenoxybenzamine—SLC22A3—lymph node—ovarian cancer	0.00084	0.00781	CbGeAlD
Phenoxybenzamine—ADRA2A—female gonad—ovarian cancer	0.000792	0.00736	CbGeAlD
Phenoxybenzamine—ADRA2A—vagina—ovarian cancer	0.000787	0.00732	CbGeAlD
Phenoxybenzamine—Clomifene—ESR1—ovarian cancer	0.000784	0.143	CrCbGaD
Phenoxybenzamine—CALM2—lymph node—ovarian cancer	0.000714	0.00664	CbGeAlD
Phenoxybenzamine—CALM1—lymph node—ovarian cancer	0.00071	0.0066	CbGeAlD
Phenoxybenzamine—ADRA2A—testis—ovarian cancer	0.000702	0.00653	CbGeAlD
Phenoxybenzamine—CYP3A4—female reproductive system—ovarian cancer	0.000685	0.00637	CbGeAlD
Phenoxybenzamine—ADRA2C—lymph node—ovarian cancer	0.000638	0.00593	CbGeAlD
Phenoxybenzamine—Tamoxifen—CYP1B1—ovarian cancer	0.000536	0.0982	CrCbGaD
Phenoxybenzamine—ADRA2A—lymph node—ovarian cancer	0.000509	0.00473	CbGeAlD
Phenoxybenzamine—Toremifene—ABCB1—ovarian cancer	0.000385	0.0705	CrCbGaD
Phenoxybenzamine—Tamoxifen—ESR1—ovarian cancer	0.000362	0.0663	CrCbGaD
Phenoxybenzamine—Clomifene—ABCB1—ovarian cancer	0.000333	0.061	CrCbGaD
Phenoxybenzamine—Propafenone—ABCB1—ovarian cancer	0.000271	0.0497	CrCbGaD
Phenoxybenzamine—Bepridil—ABCB1—ovarian cancer	0.000242	0.0443	CrCbGaD
Phenoxybenzamine—Fentanyl—ABCB1—ovarian cancer	0.000223	0.0407	CrCbGaD
Phenoxybenzamine—Tamoxifen—ABCB1—ovarian cancer	0.000154	0.0282	CrCbGaD
Phenoxybenzamine—Methadone—ABCB1—ovarian cancer	0.000153	0.0279	CrCbGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—KRAS—ovarian cancer	8.89e-06	4.39e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCND1—ovarian cancer	8.85e-06	4.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MAPK3—ovarian cancer	8.83e-06	4.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CXCL8—ovarian cancer	8.82e-06	4.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—VEGFA—ovarian cancer	8.82e-06	4.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MAPK3—ovarian cancer	8.82e-06	4.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—MAPK1—ovarian cancer	8.81e-06	4.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—MAPK1—ovarian cancer	8.81e-06	4.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—EGFR—ovarian cancer	8.8e-06	4.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—EGFR—ovarian cancer	8.8e-06	4.35e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—HRAS—ovarian cancer	8.77e-06	4.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CTNNB1—ovarian cancer	8.76e-06	4.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—STAT3—ovarian cancer	8.74e-06	4.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NRAS—ovarian cancer	8.71e-06	4.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MYC—ovarian cancer	8.69e-06	4.29e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—VEGFA—ovarian cancer	8.68e-06	4.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PTEN—ovarian cancer	8.66e-06	4.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—PIK3CA—ovarian cancer	8.64e-06	4.27e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CDKN1B—ovarian cancer	8.62e-06	4.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—KRAS—ovarian cancer	8.6e-06	4.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—STAT3—ovarian cancer	8.6e-06	4.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MYC—ovarian cancer	8.59e-06	4.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	8.59e-06	4.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MYC—ovarian cancer	8.58e-06	4.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NRAS—ovarian cancer	8.58e-06	4.24e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MAPK3—ovarian cancer	8.54e-06	4.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MAPK3—ovarian cancer	8.54e-06	4.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	8.54e-06	4.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—AKT1—ovarian cancer	8.52e-06	4.21e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MAPK1—ovarian cancer	8.5e-06	4.2e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EGFR—ovarian cancer	8.5e-06	4.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ERBB2—ovarian cancer	8.49e-06	4.19e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PIK3CA—ovarian cancer	8.47e-06	4.18e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ABCB1—ovarian cancer	8.47e-06	4.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	8.44e-06	4.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL2—ovarian cancer	8.43e-06	4.16e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MAPK1—ovarian cancer	8.4e-06	4.15e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—EGFR—ovarian cancer	8.4e-06	4.15e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MAPK1—ovarian cancer	8.39e-06	4.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EGFR—ovarian cancer	8.39e-06	4.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	8.39e-06	4.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MTOR—ovarian cancer	8.38e-06	4.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PIK3CB—ovarian cancer	8.38e-06	4.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTEN—ovarian cancer	8.37e-06	4.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTEN—ovarian cancer	8.37e-06	4.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—PIK3CA—ovarian cancer	8.36e-06	4.13e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—PIK3CA—ovarian cancer	8.36e-06	4.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MAPK3—ovarian cancer	8.35e-06	4.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	8.33e-06	4.11e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—TYMS—ovarian cancer	8.32e-06	4.11e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—KRAS—ovarian cancer	8.32e-06	4.11e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—KRAS—ovarian cancer	8.32e-06	4.11e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MYC—ovarian cancer	8.31e-06	4.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MYC—ovarian cancer	8.31e-06	4.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PIK3CA—ovarian cancer	8.24e-06	4.07e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	8.22e-06	4.06e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MAPK3—ovarian cancer	8.21e-06	4.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ERBB2—ovarian cancer	8.21e-06	4.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ERBB2—ovarian cancer	8.21e-06	4.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—PIK3CA—ovarian cancer	8.17e-06	4.03e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	8.14e-06	4.02e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MAPK1—ovarian cancer	8.13e-06	4.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MAPK1—ovarian cancer	8.13e-06	4.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—EGFR—ovarian cancer	8.13e-06	4.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—EGFR—ovarian cancer	8.13e-06	4.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MYC—ovarian cancer	8.12e-06	4.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PIK3CB—ovarian cancer	8.1e-06	4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MTOR—ovarian cancer	8.1e-06	4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MTOR—ovarian cancer	8.1e-06	4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PIK3CB—ovarian cancer	8.1e-06	4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CXCL8—ovarian cancer	8.05e-06	3.98e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—KRAS—ovarian cancer	8.03e-06	3.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—HRAS—ovarian cancer	8e-06	3.95e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MYC—ovarian cancer	7.99e-06	3.94e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	7.98e-06	3.94e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MAPK1—ovarian cancer	7.94e-06	3.92e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EGFR—ovarian cancer	7.94e-06	3.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—KRAS—ovarian cancer	7.94e-06	3.92e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	7.93e-06	3.92e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—KRAS—ovarian cancer	7.93e-06	3.91e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TP53—ovarian cancer	7.9e-06	3.9e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—PIK3CA—ovarian cancer	7.9e-06	3.9e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PIK3CA—ovarian cancer	7.9e-06	3.9e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CDKN1B—ovarian cancer	7.86e-06	3.88e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MAPK1—ovarian cancer	7.82e-06	3.86e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EGFR—ovarian cancer	7.81e-06	3.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCL8—ovarian cancer	7.79e-06	3.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCL8—ovarian cancer	7.79e-06	3.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	7.74e-06	3.82e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—HRAS—ovarian cancer	7.74e-06	3.82e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—HRAS—ovarian cancer	7.74e-06	3.82e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	7.71e-06	3.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CASP3—ovarian cancer	7.71e-06	3.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL2—ovarian cancer	7.69e-06	3.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—KRAS—ovarian cancer	7.68e-06	3.79e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—KRAS—ovarian cancer	7.68e-06	3.79e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—ovarian cancer	7.66e-06	3.78e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—PIK3CA—ovarian cancer	7.64e-06	3.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—PIK3CA—ovarian cancer	7.64e-06	3.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	7.64e-06	3.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	7.62e-06	3.76e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CDKN1B—ovarian cancer	7.61e-06	3.76e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CDKN1B—ovarian cancer	7.61e-06	3.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—HRAS—ovarian cancer	7.56e-06	3.73e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—KRAS—ovarian cancer	7.5e-06	3.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCND1—ovarian cancer	7.5e-06	3.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CASP3—ovarian cancer	7.45e-06	3.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CASP3—ovarian cancer	7.45e-06	3.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL2—ovarian cancer	7.44e-06	3.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL2—ovarian cancer	7.44e-06	3.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CTNNB1—ovarian cancer	7.43e-06	3.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—ovarian cancer	7.41e-06	3.66e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—ovarian cancer	7.41e-06	3.66e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—KRAS—ovarian cancer	7.38e-06	3.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—PIK3CA—ovarian cancer	7.38e-06	3.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HRAS—ovarian cancer	7.31e-06	3.61e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	7.3e-06	3.6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PIK3CA—ovarian cancer	7.29e-06	3.6e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—PIK3CA—ovarian cancer	7.28e-06	3.6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MMP9—ovarian cancer	7.28e-06	3.6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCND1—ovarian cancer	7.26e-06	3.58e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCND1—ovarian cancer	7.26e-06	3.58e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PTEN—ovarian cancer	7.24e-06	3.57e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—ovarian cancer	7.24e-06	3.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CTNNB1—ovarian cancer	7.18e-06	3.55e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CTNNB1—ovarian cancer	7.18e-06	3.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	7.17e-06	3.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TP53—ovarian cancer	7.14e-06	3.52e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MYC—ovarian cancer	7.1e-06	3.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	7.1e-06	3.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	7.08e-06	3.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HRAS—ovarian cancer	7.07e-06	3.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HRAS—ovarian cancer	7.07e-06	3.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—AKT1—ovarian cancer	7.06e-06	3.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PIK3CA—ovarian cancer	7.05e-06	3.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PIK3CA—ovarian cancer	7.05e-06	3.48e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TP53—ovarian cancer	7.05e-06	3.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MMP9—ovarian cancer	7.04e-06	3.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MMP9—ovarian cancer	7.04e-06	3.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PTEN—ovarian cancer	7e-06	3.46e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PTEN—ovarian cancer	7e-06	3.46e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—ovarian cancer	6.99e-06	3.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	6.94e-06	3.43e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	6.94e-06	3.43e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—AKT1—ovarian cancer	6.92e-06	3.42e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—PIK3CA—ovarian cancer	6.89e-06	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—AKT1—ovarian cancer	6.83e-06	3.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—AKT1—ovarian cancer	6.83e-06	3.37e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—HRAS—ovarian cancer	6.82e-06	3.37e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—PIK3CA—ovarian cancer	6.78e-06	3.35e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	6.78e-06	3.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—ovarian cancer	6.77e-06	3.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—ovarian cancer	6.77e-06	3.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HRAS—ovarian cancer	6.75e-06	3.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—HRAS—ovarian cancer	6.74e-06	3.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—AKT1—ovarian cancer	6.73e-06	3.32e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CAV1—ovarian cancer	6.7e-06	3.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PIK3CA—ovarian cancer	6.69e-06	3.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—AKT1—ovarian cancer	6.67e-06	3.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TP53—ovarian cancer	6.67e-06	3.29e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MYC—ovarian cancer	6.59e-06	3.26e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TP53—ovarian cancer	6.56e-06	3.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	6.56e-06	3.24e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—VEGFA—ovarian cancer	6.54e-06	3.23e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—ovarian cancer	6.53e-06	3.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HRAS—ovarian cancer	6.53e-06	3.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HRAS—ovarian cancer	6.53e-06	3.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—STAT3—ovarian cancer	6.47e-06	3.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NRAS—ovarian cancer	6.46e-06	3.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—ovarian cancer	6.46e-06	3.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—AKT1—ovarian cancer	6.45e-06	3.19e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—AKT1—ovarian cancer	6.45e-06	3.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	6.45e-06	3.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—ovarian cancer	6.45e-06	3.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	6.45e-06	3.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—HRAS—ovarian cancer	6.38e-06	3.15e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—VEGFA—ovarian cancer	6.32e-06	3.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—VEGFA—ovarian cancer	6.32e-06	3.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—HRAS—ovarian cancer	6.27e-06	3.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—STAT3—ovarian cancer	6.26e-06	3.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—STAT3—ovarian cancer	6.26e-06	3.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NRAS—ovarian cancer	6.25e-06	3.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NRAS—ovarian cancer	6.25e-06	3.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—ovarian cancer	6.25e-06	3.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—ovarian cancer	6.25e-06	3.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—AKT1—ovarian cancer	6.24e-06	3.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—AKT1—ovarian cancer	6.24e-06	3.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MAPK3—ovarian cancer	6.19e-06	3.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PIK3CA—ovarian cancer	6.11e-06	3.02e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	6.1e-06	3.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—ovarian cancer	6.1e-06	3.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	6.09e-06	3.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AKT1—ovarian cancer	6.03e-06	2.98e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	6.02e-06	2.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MYC—ovarian cancer	6.02e-06	2.97e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—ovarian cancer	6.01e-06	2.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MAPK3—ovarian cancer	5.98e-06	2.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MAPK3—ovarian cancer	5.98e-06	2.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—AKT1—ovarian cancer	5.96e-06	2.94e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AKT1—ovarian cancer	5.95e-06	2.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PIK3CA—ovarian cancer	5.91e-06	2.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PIK3CA—ovarian cancer	5.91e-06	2.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MAPK1—ovarian cancer	5.89e-06	2.91e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EGFR—ovarian cancer	5.88e-06	2.91e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TP53—ovarian cancer	5.83e-06	2.88e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MYC—ovarian cancer	5.82e-06	2.87e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MYC—ovarian cancer	5.82e-06	2.87e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—AKT1—ovarian cancer	5.76e-06	2.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—AKT1—ovarian cancer	5.76e-06	2.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MAPK1—ovarian cancer	5.69e-06	2.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MAPK1—ovarian cancer	5.69e-06	2.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EGFR—ovarian cancer	5.69e-06	2.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EGFR—ovarian cancer	5.69e-06	2.81e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AKT1—ovarian cancer	5.63e-06	2.78e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	5.6e-06	2.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	5.57e-06	2.75e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—KRAS—ovarian cancer	5.56e-06	2.74e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AKT1—ovarian cancer	5.54e-06	2.74e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—AKT1—ovarian cancer	5.47e-06	2.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TP53—ovarian cancer	5.41e-06	2.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—KRAS—ovarian cancer	5.38e-06	2.66e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—KRAS—ovarian cancer	5.38e-06	2.66e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	5.37e-06	2.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—ovarian cancer	5.33e-06	2.63e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	5.18e-06	2.56e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PIK3CA—ovarian cancer	5.11e-06	2.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—AKT1—ovarian cancer	4.99e-06	2.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—ovarian cancer	4.96e-06	2.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TP53—ovarian cancer	4.94e-06	2.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PIK3CA—ovarian cancer	4.94e-06	2.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PIK3CA—ovarian cancer	4.94e-06	2.44e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	4.92e-06	2.43e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—AKT1—ovarian cancer	4.83e-06	2.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—AKT1—ovarian cancer	4.83e-06	2.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TP53—ovarian cancer	4.78e-06	2.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TP53—ovarian cancer	4.78e-06	2.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HRAS—ovarian cancer	4.72e-06	2.33e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.68e-06	2.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	4.57e-06	2.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HRAS—ovarian cancer	4.57e-06	2.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HRAS—ovarian cancer	4.57e-06	2.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—ovarian cancer	4.52e-06	2.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—ovarian cancer	4.37e-06	2.16e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—ovarian cancer	4.37e-06	2.16e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AKT1—ovarian cancer	4.17e-06	2.06e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTEN—ovarian cancer	4.04e-06	2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AKT1—ovarian cancer	4.04e-06	1.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AKT1—ovarian cancer	4.04e-06	1.99e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.85e-06	1.41e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AKT1—ovarian cancer	2.33e-06	1.15e-05	CbGpPWpGaD
